SHORT BOWEL SYNDROME
Clinical trials for SHORT BOWEL SYNDROME explained in plain language.
Never miss a new study
Get alerted when new SHORT BOWEL SYNDROME trials appear
Sign up with your email to follow new studies for SHORT BOWEL SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Two-Year trial tests Long-Term safety of weekly injection for rare gut condition
Disease control OngoingThis is a two-year extension study for adults with short bowel syndrome who completed a previous trial. It aims to see if weekly injections of glepaglutide remain safe and effective over the long term. The study will monitor side effects and whether the treatment continues to hel…
Matched conditions: SHORT BOWEL SYNDROME
Phase: PHASE3 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New drug trial aims to free patients from IV nutrition dependence
Disease control OngoingThis study is testing the long-term safety and effectiveness of a drug called glepaglutide for people with short bowel syndrome. The trial involves 145 patients who previously participated in related studies, following them to see if the treatment continues to help reduce their n…
Matched conditions: SHORT BOWEL SYNDROME
Phase: PHASE3 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Device aims to free kids from IV feeding tubes
Disease control ENROLLING_BY_INVITATIONThis study is observing children with short bowel syndrome for an extra 90 days to see if a device called Relizorb is safe and helps them absorb fat from tube feeding. The device attaches to a feeding tube and predigests fat, which could help kids rely less on risky intravenous (…
Matched conditions: SHORT BOWEL SYNDROME
Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Mar 10, 2026 12:54 UTC
-
New program aims to ease the burden for families facing rare childhood diseases
Symptom relief ENROLLING_BY_INVITATIONThis study is testing a support program called FACE-Rare for families caring for children with serious rare diseases. The program aims to help families plan for future medical decisions and address their own support needs. Researchers want to see if this improves the family's qua…
Matched conditions: SHORT BOWEL SYNDROME
Phase: NA • Sponsor: Children's National Research Institute • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC
-
Massive study tracks Long-Term risks for rare gut condition
Knowledge-focused OngoingThis study is a large, long-term registry that aims to understand the safety and real-world outcomes for people living with short bowel syndrome. It will follow over 1,800 participants, including those who are and are not treated with the medication teduglutide, to track health e…
Matched conditions: SHORT BOWEL SYNDROME
Sponsor: Shire • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC